Search

Your search keyword '"Boudhabhay, Idris"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Boudhabhay, Idris" Remove constraint Author: "Boudhabhay, Idris"
48 results on '"Boudhabhay, Idris"'

Search Results

5. The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms

9. Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis

10. Kidney involvement in myelodysplastic syndromes.

13. Épargne néphronique dans la prise en charge des tumeurs rénales malignes solides localisées

17. Imagerie des cancers et prévention de l’insuffisance rénale

18. Percutaneous Thermal Ablation for Renal Tumors in Patients with Birt–Hogg–Dubé Syndrome

21. Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients

22. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

23. Authors’ Reply

24. COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection

25. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

28. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

29. Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome

31. Impact of pre‐eclampsia on renal outcome in sickle cell disease patients

32. Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths

33. Challenging diagnosis of renal failure associated with severe neurological symptoms in a patient with mixed connective tissue disease

36. Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis

37. Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy

38. Impact of hypertensive emergency and complement rare variants on presentation and outcome of atypical hemolytic uremic syndrome

42. Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome

44. [Nephron sparing in the management of localized solid renal mass].

45. [Cancer imaging and prevention of renal failure].

46. The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms.

47. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.

48. Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

Catalog

Books, media, physical & digital resources